Sweden
· Delayed Price · Currency is SEK Level Bio AB Company Description
Level Bio AB (publ) designs, develops, and distributes diagnostics products in the Nordic region and internationally.
The company distributes equipment; consumables and reagents for molecular biology; and research and diagnostic products in Sweden and the Nordics.
It also develops, produces, and sells products for genetic fetal diagnostics, as well as genetic miscarriage and infertility diagnostics products.
In addition, the company engages in the development of products for congenital heart defect. Its product portfolio includes Rob, an automated 96/384 qPCR setup; BugScreener, a system for screening methicillin resistant staphylococcus aures; and aAmp, a thermal cycler that utilizes SuperConvection technology, which enables accurate PCR assays.
The company was formerly known as AlphaHelix Molecular Diagnostics AB (publ) and changed its name to Level Bio AB (publ) in May 2024.
Level Bio AB (publ) was incorporated in 1998 and is headquartered in Stockholm, Sweden.
| Country | Sweden |
| Founded | 1998 |
| Industry | In Vitro and In Vivo Diagnostic Substances |
| Employees | 13 |
| CEO | Joakim Granemo |
Contact Details
Address: Västra Finnbodavägen 4B Stockholm, 131 30 Sweden | |
| Phone | 46 86 26 76 00 |
| Website | levelbio.se |
Stock Details
| Ticker Symbol | LEVBIO |
| Exchange | Nordic Growth Market |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| SIC Code | 2835 |
Key Executives
| Name | Position |
|---|---|
| Joakim Granemo | Chief Executive Officer |
| Ulrica Karlsson | Chief Financial Officer |